LATEST / HEALTH
GUIDEHEALTH EARNS URAC HEALTH CARE AI ACCREDITATION / AUG 2026EMORY BACKS CARE BEYOND THE EXAM ROOM / $10M STRATEGIC INVESTMENT

COMPANY / HEALTH × AI / THE FOLLOW-THROUGH

Guidehealth and the art of care between appointments

A blood-pressure phone call reveals the wager behind Guidehealth: healthcare gets cheaper when someone finishes the work between visits. Its answer combines AI outreach, human care teams and the unglamorous business of getting care delivered.

In December 2024, the problem was a telephone. A Guidehealth customer needed blood-pressure readings from thousands of older patients, quickly. The readings existed somewhere beyond the medical record: in homes, on cuffs, with people who had to be reached. A care gap had become a calling problem.

In an April 2026 interview, founder Sanjay Doddamani described using an AI voice concierge to collect more than 2,000 readings. About 15% came back elevated and needed escalation, according to the interview account. A raised reading is a reason for clinical follow-up, rather than a diagnosis on its own. The useful discovery was that an outreach task could also reveal people who needed attention.

THE STORY IN 30 SECONDS
  • Guidehealth sells healthcare organizations a combination of technology, care teams and administrative services.
  • Its human Healthguides work alongside conversational AI, with escalation when a person needs more support.
  • Buying Arcadia’s services operation gave the startup an established back office.
  • Emory became a partner in 2024 and a $10 million investor in 2025.

This is a useful way into a company whose market can otherwise sound like a cabinet full of abstractions: population health, value-based care, benefits enablement. The call makes the business legible. Someone needs information. Someone has to obtain it. Someone then has to do something with it.

The telephone test

Guidehealth operates in the interval between those three steps. A physician may have a sensible plan, a health system may have a sophisticated record, and a patient may sincerely intend to follow instructions. None guarantees that the next appointment is booked or that the relevant information gets back to the right clinician.

The company’s current approach combines predictive intelligence, a conversational voice system called RoseConnect and human Healthguides and nurses. The ambition is to extend the capacity of existing practices beyond the exam room. The patient keeps a relationship with the provider; Guidehealth supplies additional machinery and people around it.

2,000+readings collected
~15%reported elevated

December 2024 campaign, recounted in an April 2026 founder interview. Reported results, not an independent clinical evaluation.

The lesson of the campaign is narrower, and more interesting, than the claim that AI can do healthcare. Obtaining a home reading is a bounded task. Deciding how to respond to an elevated result requires a care pathway. The economics improve only if the automated part and the human part cooperate.

Buy the machinery, then change the economics

Guidehealth began in 2023. Doddamani brought experience as a cardiologist, a senior adviser at the Center for Medicare and Medicaid Innovation, and chief medical officer of Geisinger at Home. Co-founder Michael Gleeson had led strategy and innovation at Arcadia, the healthcare data company. The current leadership roster also names physician Mark Selna as a co-founder.

Guidehealth founder and CEO Sanjay DoddamaniGuidehealth co-founder Michael Gleeson
The doctor and the data man. Sanjay Doddamani, left, and Michael Gleeson bring clinical care and analytics experience to the same operating problem. Portraits: Guidehealth.

In December 2023, the young company bought Arcadia’s value-based care service division and managed services organization. It also agreed to use Arcadia’s analytics platform. The acquisition brought capabilities such as referral management, prior authorizations, network administration and claims payments. This was a shortcut to operating experience, rather than a promise to invent every part of healthcare anew.

There was a financial puzzle behind the purchase. Hospitals can lose revenue when successful prevention reduces admissions. Guidehealth’s early pitch paired stronger performance in value-based contracts with appropriate referrals through an affiliated network. Keeping a patient out of an avoidable hospital stay and helping another patient obtain needed specialist care can serve the same system.

“Health systems have a very underrecognized asset.”Sanjay Doddamani, on established physician networks, August 2024

That positioning helps distinguish Guidehealth from a pure analytics vendor. It also places the company alongside value-based care enablers such as Aledade and Pearl Health, although their customers and arrangements differ. Guidehealth’s early named customers included Endeavor Health and the Amita Health Care Network. Its organizing unit is the provider network, with all the practical difficulties that implies.

A brain, a voice and someone who can act

The company’s own shorthand is “brain, voice and touch.” The brain supplies clinical intelligence and targeting. The voice handles outreach. The touch is the human care team. There is something pleasingly unfashionable about giving an AI business a third component made of people.

Guidehealth markets two connected service areas. Health Enablement covers personalized care plans, engagement, documentation and quality improvement. Benefits Enablement covers claims, eligibility-related administration, prior authorization and medical necessity. One addresses what care should happen; the other addresses the paperwork and permissions that help it happen.

The company has also assembled specialist partners. In July 2024, Story Health and Guidehealth announced a cardiology program for health systems and clinically integrated networks. Healthguides would identify suitable patients and help enroll them. Story Health’s clinical team would provide specialty support, with providers kept informed and involved in escalations.

In August 2025, Firstsource joined the network of partners, combining operational automation with Guidehealth’s analytics and clinical expertise for health plans. The practical bet is that an organization will buy coordinated capabilities instead of having to stitch together separate vendors, staff and workflows itself.

Emory moves from customer to investor

Emory Healthcare offers a particularly concrete example. In November 2024, it announced a Population Health Collaborative with Guidehealth aimed at more than 350,000 people across Georgia. The initiative brought together Emory’s primary care service line and affiliated physician network, with more than 500 primary care and affiliate providers.

Emory’s explanation stressed integration into clinical workflows. That detail matters. A useful tool that creates another disconnected task can still become a burden. Embedding additional support in the practice is part of what the customer is buying.

In June 2025, Emory invested $10 million. Reporting on the collaboration described work on a Medicare Advantage patient panel of 27,000: the number of quality measures rated above four stars rose from one to six. Those are measure-level results, rather than a declaration that an entire plan suddenly earned six stars. They are reported partner outcomes and do not, by themselves, isolate Guidehealth’s effect.

TWO DISCLOSED INVESTMENTS
Aug 2024 / Seed
$14M
Jun 2025 / Emory
$10M

$24 million combined. Capital raised is not the price a customer pays.

By July 2026, the relationship also had an everyday expression in Emory’s employee bulletin. Eligible employees and covered dependents enrolled in Aetna POS or Aetna HSA plans could use Guidehealth care management at no additional cost. Nurses and care coordinators worked alongside existing providers. For a person navigating recovery or a chronic condition, this is the service in plain English: help finding and coordinating the next step.

The price of getting the handoff right

Guidehealth’s business model blends technology and services. Early reporting described technology fees, participation in value-based risk arrangements and a share of generated savings. The incentives resemble the work: success depends on operating performance, not simply issuing software accounts.

Its acquisition and partnership choices help explain how it intends to control costs. An established services operation supplies practical know-how. Outside platforms supply some of the technology. Automated outreach can reserve staff attention for cases that require it. These choices also make integration a central managerial task.

Trust has acquired some external structure. Guidehealth MSO announced a three-year URAC Health Utilization Management accreditation in September 2025. In August 2026, URAC named Guidehealth among the first three recipients of its Health Care AI Accreditation. The latter concerns AI governance and processes; it does not certify an AI system’s clinical effectiveness.

The transferable idea is to start with one task that has a clear finish line, then design the escalation before increasing the volume. Good patient context, reachable people and available clinical support are necessary parts of that logic. A faster calling system cannot supply an appointment slot, repair an inaccurate record or create a nurse’s time. An organization also needs financial arrangements that make prevention worth funding.

Guidehealth’s wager is that the neglected work can become an organized service: collect the reading, book the referral, clarify the benefit, close the loop. The achievement worth watching is whether more patients get the next piece of care without making the practice chase every loose end. Healthcare has plenty of plans. Finishing one is a respectable business.